A detailed history of Sawyer & Company, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Sawyer & Company, Inc holds 24,473 shares of ABT stock, worth $2.81 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
24,473
Previous 24,548 0.31%
Holding current value
$2.81 Million
Previous $2.55 Million 9.37%
% of portfolio
1.03%
Previous 1.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$100.07 - $118.13 $7,505 - $8,859
-75 Reduced 0.31%
24,473 $2.79 Million
Q2 2024

Jul 31, 2024

SELL
$100.73 - $112.44 $15,613 - $17,428
-155 Reduced 0.63%
24,548 $2.55 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $39,427 - $43,545
-360 Reduced 1.44%
24,703 $2.81 Million
Q4 2023

Jan 17, 2024

SELL
$90.19 - $110.4 $97,315 - $119,121
-1,079 Reduced 4.13%
25,063 $2.76 Million
Q3 2023

Oct 25, 2023

SELL
$95.53 - $114.62 $9,075 - $10,888
-95 Reduced 0.36%
26,142 $2.53 Million
Q1 2023

Apr 19, 2023

SELL
$96.86 - $114.01 $22,665 - $26,678
-234 Reduced 0.88%
26,237 $2.72 Million
Q4 2022

Jan 11, 2023

BUY
$95.06 - $111.52 $51,332 - $60,220
540 Added 2.08%
26,471 $2.91 Million
Q3 2022

Oct 25, 2022

BUY
$96.76 - $112.03 $2,515 - $2,912
26 Added 0.1%
25,931 $2.51 Million
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $4,902 - $5,978
-43 Reduced 0.17%
25,905 $3.07 Million
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $12,246 - $14,994
-106 Reduced 0.41%
25,948 $3.65 Million
Q3 2021

Nov 03, 2021

BUY
$116.66 - $129.06 $37,914 - $41,944
325 Added 1.26%
26,054 $3.08 Million
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $29,621 - $34,868
280 Added 1.1%
25,729 $2.98 Million
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $43,536 - $51,291
-400 Reduced 1.55%
25,449 $3.05 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $21,000 - $22,884
-200 Reduced 0.77%
25,849 $2.83 Million
Q3 2020

Oct 20, 2020

SELL
$91.64 - $111.29 $59,199 - $71,893
-646 Reduced 2.42%
26,049 $2.84 Million
Q2 2020

Jul 31, 2020

SELL
$76.57 - $98.0 $22,588 - $28,910
-295 Reduced 1.09%
26,695 $2.44 Million
Q1 2020

May 06, 2020

SELL
$62.82 - $91.86 $27,012 - $39,499
-430 Reduced 1.57%
26,990 $2.13 Million
Q4 2019

Jan 13, 2020

BUY
$78.51 - $87.4 $28,263 - $31,464
360 Added 1.33%
27,420 $2.38 Million
Q3 2019

Oct 17, 2019

SELL
$81.84 - $88.74 $70,791 - $76,760
-865 Reduced 3.1%
27,060 $2.26 Million
Q2 2019

Jul 23, 2019

SELL
$72.88 - $85.0 $72,880 - $85,000
-1,000 Reduced 3.46%
27,925 $2.35 Million
Q1 2019

May 06, 2019

SELL
$66.22 - $80.06 $9,933 - $12,009
-150 Reduced 0.52%
28,925 $2.31 Million
Q4 2018

Jan 25, 2019

SELL
$65.56 - $74.27 $65,232 - $73,898
-995 Reduced 3.31%
29,075 $2.1 Million
Q3 2018

Oct 22, 2018

SELL
$60.81 - $73.36 $9,425 - $11,370
-155 Reduced 0.51%
30,070 $2.21 Million
Q4 2017

Jan 11, 2018

BUY
$53.68 - $57.47 $1.62 Million - $1.74 Million
30,225
30,225 $1.73 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sawyer & Company, Inc Portfolio

Follow Sawyer & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.